Corporate Parent Hospital Partners of America Files Voluntary Chapter 11 Petition; Filings do not Include any Hospital Facilities

Filings to Facilitate Orderly Sale and Disposition of Hospital Assets Patient Care to Remain Uninterrupted At HPA Hospitals CHARLOTTE, N.C., Sept. 24 /PRNewswire/ -- Hospital Partners of America ("HPA" or "the Company") announced today that it and certain intermediate entities have filed vol...

KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission

Company Files Fiscal Form 10-Q's for First Three Quarters of Fiscal 2008 and Form 10-K for Fiscal 2008 Ended March 31, 2008 Points to Positive Fiscal 2009 Outlook for Its Branded and Generic Pharmaceutical Businesses ST. LOUIS, June 25 /PRNewswire-FirstCall/ -...

KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings

KV Expects Filings To Be Completed Within Automatic Form 10-K Extension Period ST. LOUIS, May 30 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and ma...

Perr&Knight Announces Discounted Fee Schedule for Access to Its Online Database of Commercial Lines Competitor Filings

LOS ANGELES, April 22 /PRNewswire/ -- For a limited time, Perr&Knight is offering a discounted fee schedule for commercial lines writers who are interested in obtaining their competitors' rate, rule and form filings from around the country online at RateFilings.com. RateFilings.com features ...

MDS Inc. Issues Annual Filings

All Financial Statements for 2007 Now Available in US GAAP TORONTO, Jan. 29 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has issued its annual filings for the first time ...

Medical International Technology Inc. "MIT" announces that it has completed its 10QSB quarterly reports and has become up to date with its filings

DENVER, CO, Nov. 15 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), is pleased to announce that it has completed its 10QSB quarterly reports (December 2006, March 2007 and June 2007) and has become up to date with...

MedQuist Updates Status of Outstanding SEC Filings

MT. LAUREL, N.J., Sept. 28 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ.PK) today announced that it is nearing completion of the work on its Forms 10-Q for the first two quarters of 2007 and expects filing both reports with the Securities and Exchange Commission (SEC) by the midd...

China Medical Technologies Announces Change of Independent Auditors

...ts to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update a...

Watson Announces Limited Recall Of Fentanyl Transdermal System

...ming or outcome of FDA or other regulatory agency approvals or actions, if any; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Quarterly Report on Form 10-Q for the period ended June 30, 2009. ...

Nuvo Announces 2009 second quarter financial results

...hese forward-looking statements, investors should consult the Company's ongoing quarterly filings, annual report and Annual Information Form and other filings found on SEDAR at www.sedar.com . Summary financial statements attached: NUVO RESEARCH INC. ...

filings in Medical Technology

Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe

OSAKA, Japan, June 3 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it has reviewed the development strategy for the Marketing Authorization Applications (MAAs) for its investigational compounds, alogliptin and alogliptin/ACTOS (generic name: pioglitazone H...

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)

TITUSVILLE, N.J., Feb. 6 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced that the company has submitted multiple applications to the U.S. Food and Drug Administration (FDA) which, if approved, would broaden treatment options for...

Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings

NEWTON, Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "Advancing Drugs Through Glycoscience(R)", today updated the progress of its Phase II clinical trial for first-line treatment of metastatic, unresectable colorectal cancer patients who are unable to toler...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...ied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking State...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...d the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to ...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... about Novavax is available at www.novavax.com and in the company's various filings with the Securities and Exchange Commission. Forward Looking Statem..., financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at ...

2,500 Cases Completed With the Magnetic Irrigated Catheter

...rs, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statemen...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

...usiness is included under the heading "Risk Factors" in Tower's most recent filings on Forms 20-F, F-3, F-4 and 6-K, as were filed with the Securities and Exch...sion (the "SEC") and the Israel Securities Authority and Jazz's most recent filings on Forms 10-K and 10-Q, as were filed with the SEC. Tower and Jazz do not i...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

...aintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission. For further information please contact: Investor Relations Clea Rosenfeld (Rest of the World)...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

...also review the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not...

filings in Biological News

ComCam Selected by ePortation on New Maritime Domain Awareness Project

...c to read the information provided here in conjunction with its most recent filings on Form 10-K and Form 10-Q. ComCam's public filings may be viewed at http://www.sec.gov. Contact: Susan Schoch...

Aware, Inc. Reports Second Quarter 2009 Financial Results

...sion, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2008 and other reports and filings made with the Securities and Exchange Commission. Aware, StratiPHY, and Dr. DSL are trademarks or registered trademarks of Aware, Inc. ...

delSECUR CORPORATION Announces Appointment of the Company's President & CEO

...market conditions, changes in laws and regulation affecting these industries and numerous other factors discussed in this release and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. ...

Aware, Inc. Reports First Quarter 2009 Financial Results

...sion, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2008 and other reports and filings made with the Securities and Exchange Commission. Aware, StratiPHY, and Dr. DSL are trademarks or registered trademarks of Aware, Inc. ...

Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics

...actors that may affect the future performance of BIO-key International, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only a...

Aware, Inc. Reports First Quarter 2009 Financial Results

...sion, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2008 and other reports and filings made with the Securities and Exchange Commission. Aware, StratiPHY, and Dr. DSL are trademarks or registered trademarks of Aware, Inc. ...

Aware, Inc. Announces Final Results of Dutch Auction Tender Offer

...future performance. Additional cautionary statements regarding risks that could have an effect on the future performance of Aware are contained in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2008. The statement...

Aware, Inc. Amends and Extends Dutch Auction Tender Offer

... in the tender offer, or other conditions to completion of the tender offer are not satisfied. For further details of these risks, you should read our filings with the Securities and Exchange Commission related to the tender offer, including our Schedule TO and the documents referred to therein. The st...

Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution

...actors that may affect the future performance of BIO-key International, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only ...

Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer

... the expected number of shares to be purchased, the proration factor, and the price per share. For further details of these risks, you should read our filings with the Securities and Exchange Commission related to the tender offer, including our Schedule TO and the documents referred to therein. The st...

filings in Biological Technology

LPBP Inc. - Re-filing certification of interim filings

TORONTO, Aug. 15 /PRNewswire/ - LPBP Inc. (LPBP) - At the request of the Ontario Securities Commission, LPBP is re-filing the Certificates of the President and Chief Executive Officer and of the Chief Financial Officer of the Company in respect of its interim filings for the quarters ended Jan...

Business Filings releases software to help small businesses

MADISON - Business Filings Inc., a provider of services that help small businesses incorporate, has announced its release of a web-based application that businesses can use to manage annual state requirements. BizComply sends e-mails to business owners reminding them of due dates for annual re...

Small businesses to benefit from Business Filings partnership

Sample newsletter Source: Constant Contact MADISON For small businesses, sometimes getting the company name out is a primary concern and Business Filings Incorporated is working to help these fledglings utilize the Internet for marketing. Through a partnership with e-mail marketing compan...

Wisconsin DFI makes company filings available online

The state Department of Financial Institutions has started distributing certified copies of annual reports, articles of incorporation and other papers for a fee through its Web site. Under the heading "QuickFile," this DFI program also includes forms for filing annual reports or forming Wiscon...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...ult in cross default under, and the acceleration of, other indebtedness of the Company; and (30) the risks detailed from time-to-time in the Company's filings with the SEC. This discussion is not exhaustive, but is designed to highlight important factors that may impact the Company's forward-looking s...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...s are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission. Such filings are available on our website or at www.sec.gov. You are cautioned that such...

Novavax Reports Second Quarter 2009 Financial Results

... about Novavax is available at www.novavax.com and in the Company's various filings with the Securities and Exchange Commission. Conference Call No..., financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...2009 that the Company has filed with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not ...

NeurogesX Reports Second Quarter 2009 Results

...ogesX' product candidates. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. NEUROGESX, INC. (A Developme...

AOBO Announces New Product Launch

...erially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-K for the year ended December 31, 2008, may cause actual results or events to diffe...